Lisa Paschold
Ernst Grube Str. 40
Halle, NI 06120, Germany
Halle, NI 06120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.
Journal: Communications medicine
Published: February 23, 2026
Donor demographics and leukopak consistency: Yield and composition as operational benchmarks for cell-therapy starting materials.
Journal: Current research in translational medicine
Published: October 24, 2025
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study.
Journal: Scientific reports
Published: April 10, 2025
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.
Journal: NPJ precision oncology
Published: December 09, 2024
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trial.
Journal: Med (New York, N.Y.)
Published: October 30, 2024
Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors.
Journal: The Journal of allergy and clinical immunology
Published: October 08, 2024
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors.
Journal: Science advances
Published: August 21, 2024
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.
Journal: Cancer immunology research
Published: June 15, 2024
T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas.
Journal: Haematologica
Published: March 01, 2024
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial.
Journal: JAMA network open
Published: January 23, 2024
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection.
Journal: Hepatology communications
Published: November 14, 2023
Last Updated: 09/26/2026